ArticleInternational journal of molecular sciences2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on
Madison Bittner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.